Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Insights into clonal and CBC changes at disease evolution among ccus patients

Yazan Jabban, Rong He, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic, David Viswanatha, James Foran, Talha Badar, Cecilia Arana Yi, Yael Kusne, Antoine Saliba, Mehrdad Hefazi Torghabeh, Aasiya Matin, William Hogan, Abhishek Mangaonkar, Mithun Shah, Hassan Alkhateeb, Mrinal Patnaik, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 5621.

https://doi.org/10.1182/blood-2025-5621

Published: 2025

Journal Articles

Clinicopathologic features of myeloid neoplasms and pre-neoplasms with isolated ZRSR2 mutations

Alma Oskarsdottir, Rong He, Jennifer Jiang, Mahmoud Yacout, Patricia Greipp, Mithun Shah, Hassan Alkhateeb, David Viswanatha, Fiona Craig, Katalin Kelemen, Aref Al-Kali, Dragan Jevremovic

Blood (2025) 146 (Supplement 1): 7394.

https://doi.org/10.1182/blood-2025-7394

Published: 2025

Journal Articles

Blast clearance dynamics and time to response across IDH1- and IDH2-mutated AML

Blood (2025) 146 (Supplement 1): 7045.

https://doi.org/10.1182/blood-2025-7045

Published: 2025

Journal Articles

Reduced overall survival in TP53-mutated ccus is driven by prior cytotoxic exposure and cytopenia rather than leukemic progression

Blood (2025) 146 (Supplement 1): 5643.

https://doi.org/10.1182/blood-2025-5643

Published: 2025

Journal Articles

ETNK1 mutations define a distinct subset of myeloid neoplasms with unique cytogenetic and molecular features

Steven Tessier, Najla Al Ali, Michael Trinh, Andrew Brunner, Diletta Fontana, Carlo Gambacorti-Passerini, Rocco Piazza, David Sallman, Eric Padron, Zhuoer Xie, James Foran, Cecilia Arana Yi, Hassan Alkhateeb, Mithun Shah, Rami Komrokji, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2025-3864

Published: 2025

Journal Articles

Consideration of genomic determinants improves the diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia

Blood (2025) 146 (Supplement 1): 3849.

https://doi.org/10.1182/blood-2025-3849

Published: 2025

Journal Articles

We're not talking about sex: Hematopoietic stem cell transplant provider practices and barriers to sexual health discussions with adolescents and young adults

Brittany Kimball, Mira Kohorst, Asmaa Ferdjallah, Anand Srinivasan, Hannah Nordhues, David Dingli, Hassan Alkhateeb, Urshila Durani

Blood (2025) 146 (Supplement 1): 2872.

https://doi.org/10.1182/blood-2025-2872

Published: 2025

Journal Articles

Molecular association with elevated LDH levels in patients with AML

Oudai Alkabbani, Yazan Jabban, Rong He, David Viswanatha, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic, Antoine Saliba, Mehrdad Hefazi Torghabeh, Aasiya Matin, William Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mrinal Patnaik, Mithun Shah, Kebede Begna, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 7039.

https://doi.org/10.1182/blood-2025-7039

Published: 2025

Journal Articles

Risk-adjusted comparison of survival in chronic myelomonocytic leukemia with and without allogeneic stem cell transplant: Mayo Clinic experience in 775 consecutive patients

Blood (2025) 146 (Supplement 1): 5636.

https://doi.org/10.1182/blood-2025-5636

Published: 2025

Journal Articles

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Blood (2025) 146 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2025-2087

Published: 2025

Journal Articles

Clinical and biological correlates of blast-transformed chronic myelomonocytic leukemia (CMML): A multicenter study of 493 paired cases at chronic phase and at blast transformation

Blood (2025) 146 (Supplement 1): 2081.

https://doi.org/10.1182/blood-2025-2081

Published: 2025

Journal Articles

LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML)

Abhishek Mangaonkar, Jenna Fernandez, Ashya Burgess, Kristen McCullough, Christy Finke, Terra Lasho, Michelle Amundson, Antoine Saliba, Aasiya Matin, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Betsy Knopf, Thomas Witzig, Mrinal Patnaik

Blood (2025) 146 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2025-2079

Published: 2025

Journal Articles

AI multimodal large language model on CAR-T pre-leukapheresis evaluation to predict monitoring needs post infusion for early dismissal planning

Blood (2025) 146 (Supplement 1): 6131.

https://doi.org/10.1182/blood-2025-6131

Published: 2025

Journal Articles

Acute leukemia during pregnancy: A three-decade Mayo Clinic experience

Brittany Kimball, Antoine Saliba, Mahsa Rezasoltani, Kristen McCullough, William Hogan, Mrinal Patnaik, Isla Johnson, Clifford Csizmar, Aldo Acosta Medina, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Animesh Pardanani, Nandita Khera, Mark Litzow, Ayalew Tefferi, Naseema Gangat

Blood (2025) 146 (Supplement 1): 6408.

https://doi.org/10.1182/blood-2025-6408

Published: 2025

Journal Articles

Causes of death in DDX41-mutated myeloid neoplasms: A retrospective study

Blood (2025) 146 (Supplement 1): 7370.

https://doi.org/10.1182/blood-2025-7370

Published: 2025

Journal Articles

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Blood (2025) 146 (Supplement 1): 6750.

https://doi.org/10.1182/blood-2025-6750

Published: 2025

Journal Articles

Large language model for abstraction of CAR-T therapy toxicities data

Blood (2025) 146 (Supplement 1): 6139.

https://doi.org/10.1182/blood-2025-6139

Published: 2025

Journal Articles

Post-FDA approval experience with momelotinib in JAK inhibitor-naïve myelofibrosis: Focus on anemia response and treatment-emergent nephropathy and peripheral neuropathy

Ayalew Tefferi, Maymona Abdelmagid, Jeanne Palmer, Aref Al-Kali, Cecilia Arana Yi, Aasiya Matin, Hassan Alkhateeb, Talha Badar, Yassin Bashir, Kaaren Reichard, Rong He, Animesh Pardanani, Naseema Gangat

Blood (2025) 146 (Supplement 1): 3791.

https://doi.org/10.1182/blood-2025-3791

Published: 2025

Journal Articles

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

Blood (2025) 146 (Supplement 1): 1605.

https://doi.org/10.1182/blood-2025-1605

Published: 2025

Journal Articles

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

Blood (2025) 146 (Supplement 1): 1602.

https://doi.org/10.1182/blood-2025-1602

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Insights into clonal and CBC changes at disease evolution among ccus patients

Clinicopathologic features of myeloid neoplasms and pre-neoplasms with isolated ZRSR2 mutations

Blast clearance dynamics and time to response across IDH1- and IDH2-mutated AML

Reduced overall survival in TP53-mutated ccus is driven by prior cytotoxic exposure and cytopenia rather than leukemic progression

ETNK1 mutations define a distinct subset of myeloid neoplasms with unique cytogenetic and molecular features

Consideration of genomic determinants improves the diagnostic accuracy of oligomonocytic chronic myelomonocytic leukemia

We're not talking about sex: Hematopoietic stem cell transplant provider practices and barriers to sexual health discussions with adolescents and young adults

Molecular association with elevated LDH levels in patients with AML

Risk-adjusted comparison of survival in chronic myelomonocytic leukemia with and without allogeneic stem cell transplant: Mayo Clinic experience in 775 consecutive patients

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Clinical and biological correlates of blast-transformed chronic myelomonocytic leukemia (CMML): A multicenter study of 493 paired cases at chronic phase and at blast transformation

LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML)

AI multimodal large language model on CAR-T pre-leukapheresis evaluation to predict monitoring needs post infusion for early dismissal planning

Acute leukemia during pregnancy: A three-decade Mayo Clinic experience

Causes of death in DDX41-mutated myeloid neoplasms: A retrospective study

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Large language model for abstraction of CAR-T therapy toxicities data

Post-FDA approval experience with momelotinib in JAK inhibitor-naïve myelofibrosis: Focus on anemia response and treatment-emergent nephropathy and peripheral neuropathy

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only